Domain > academie.crescendopharma.com

More information on this domain is in AlienVault OTX

DNS Resolutions

Date	IP Address
2018-06-26	34.203.160.229 (ClassC)
2018-12-22	34.200.71.126 (ClassC)
2024-12-26	172.64.152.97 (ClassC)

HTTP/1.1 403 ForbiddenDate: Thu, 26 Dec 2024 19:30:40 GMTContent-Type: text/html; charsetUTF-8Transfer-Encoding: chunkedConnection: closeAccept-CH: Sec-CH-UA-Bitness, Sec-CH-UA-Arch, Sec-CH-UA-Full-Version, Sec-CH-UA-Mobile, Sec-CH-UA-Model, Sec-CH-UA-Platform-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Platform, Sec-CH-UA, UA-Bitness, UA-Arch, UA-Full-Version, UA-Mobile, UA-Model, UA-Platform-Version, UA-Platform, UACritical-CH: Sec-CH-UA-Bitness, Sec-CH-UA-Arch, Sec-CH-UA-Full-Version, Sec-CH-UA-Mobile, Sec-CH-UA-Model, Sec-CH-UA-Platform-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Platform, Sec-CH-UA, UA-Bitness, UA-Arch, UA-Full-Version, UA-Mobile, UA-Model, UA-Platform-Version, UA-Platform, UACross-Origin-Embedder-Policy: require-corpCross-Origin-Opener-Policy: same-originCross-Origin-Resource-Policy: same-originOrigin-Agent-Cluster: ?1Permissions-Policy: accelerometer(),autoplay(),browsing-topics(),camera(),clipboard-read(),clipboard-write(),geolocation(),gyroscope(),hid(),interest-cohort(),magnetometer(),microphone(),payment(),publickey-credentials-get(),screen-wake-lock(),serial(),sync-xhr(),usb()Referrer-Policy: same-originX-Content-Options: nosniffX-Frame-Options: SAMEORIGINcf-mitigated: challengecf-chl-out: p3rF/q3r9DIxPwKGzljHGNVnQpyJT5PAwJKAPXT1daF8DSrgXGGlsy83vbfxeGWA0n0Aop4lsgYen3UJyIGqi5km6N4sticb0mw+K2M2XLQD5zkJtCUE5uwZ1tgcEFk8QhsCbLedRm4dch0MxHtDnA$88Ylrr9S5YTZ45MFrWmu7gCache-Control: private, max-age0, no-store, no-cache, must-revalidate, post-check0, pre-check0Expires: Thu, 01 Jan 1970 00:00:01 GMTSet-Cookie: __cf_bmHZ9wQxsNUEgvzy8Qt6pFTmKz525G9eTLoGHend601Pw-1735241440-1.0.1.1-ZQSn3LFNvmMoFDrwXOzkYbgG6X4VQZB862FOXKt6qG_1t0qQj6VkPsooDF6v4Kk9QguR89WWHV0yo44UIRQdaQ; path/; expiresThu, 26-Dec-24 20:00:40 GMT; domain.academie.crescendopharma.com; HttpOnly; SecureStrict-Transport-Security: max-age63072000; includeSubDomains; preloadServer: cloudflareCF-RAY: 8f837c9bd8ee2f27-PDX

!DOCTYPE html>html langen-US>head>title>Just a moment.../title>meta http-equivContent-Type contenttext/html; charsetUTF-8>meta http-equivX-UA-Compatible contentIEEdge>meta namerobots contentnoindex,nofollow>meta nameviewport contentwidthdevice-width,initial-scale1>style>*{box-sizing:border-box;margin:0;padding:0}html{line-height:1.15;-webkit-text-size-adjust:100%;color:#313131;font-family:system-ui,-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Helvetica Neue,Arial,Noto Sans,sans-serif,Apple Color Emoji,Segoe UI Emoji,Segoe UI Symbol,Noto Color Emoji}body{display:flex;flex-direction:column;height:100vh;min-height:100vh}.main-content{margin:8rem auto;max-width:60rem;padding-left:1.5rem}@media (width  720px){.main-content{margin-top:4rem}}.h2{font-size:1.5rem;font-weight:500;line-height:2.25rem}@media (width  720px){.h2{font-size:1.25rem;line-height:1.5rem}}#challenge-error-text{background-image:url(data:image/svg+xml;base64,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);background-repeat:no-repeat;background-size:contain;padding-left:34px}@media (prefers-color-scheme:dark){body{background-color:#222;color:#d9d9d9}}/style>meta http-equivrefresh content390>/head>body classno-js>div classmain-wrapper rolemain>div classmain-content>noscript>div classh2>span idchallenge-error-text>Enable JavaScript and cookies to continue/span>/div>/noscript>/div>/div>script>(function(){window._cf_chl_opt{cvId: 3,cZone: academie.crescendopharma.com,cType: managed,cRay: 8f837c9bd8ee2f27,cH: 1tFonVKqTjD6NT.9s0XEhheniTzwTkA9yH13qvzvB0Q-1735241440-1.2.1.1-q8nJIhCt1ebJ_CabOW1hmcCNh4IAm7CH197cbxeQ3O3TGsW5vOCyYI3dlb2Qr71t,cUPMDTk: \/?__cf_chl_tkUF15sgPLJ7ctjbii6.LBGDrh5sLL3iGKaNro5w6Itec-1735241440-1.0.1.1-Ac9rwdB5j1YiUo2HXdruPJXi_bzQTYdGZtQa9XwtYfc,cFPWv: b,cITimeS: 1735241440,cTTimeMs: 1000,cMTimeMs: 390000,cTplC: 0,cTplV: 5,cTplB: cf,cK: ,fa: \/?__cf_chl_f_tkUF15sgPLJ7ctjbii6.LBGDrh5sLL3iGKaNro5w6Itec-1735241440-1.0.1.1-Ac9rwdB5j1YiUo2HXdruPJXi_bzQTYdGZtQa9XwtYfc,md: 2SAyBvfZ25Om1es887XXjPn7bJlUDvq.h4tf9g6pxX8-1735241440-1.2.1.1-Yj_C08nodjlFnw9MzpLeWNDoTQc4mFmOdYIQ8YvPmeid7arY1MqsAFaO04YBiE8DSKFggTlqwn9KBCKd3vhPqQxjEZXeLUOzsxnk0aUaLxSjssYRZ8oZJo2za9_ICK4zapUNg4.NffbfZD8z_Bwx56LgL55G2TRRjY7ru5grpil_uGYhu8p4y15d0Q6UALQgx0Hgy2OXYAo9EKh6zGtYKA.u8xEw1aAb9hiwEiAHQd2zNipdStbm2vG1a18ADCyggYJcoMgxnJhw3WifiGZIlVtD.j5GwoDBHcS..QqmJeUyVhxHpYXUV2LCF3M_1.lSVaKQDcdtwKQywc8usa.EAoRzIuxn8yvIJIeunaZyFUkGEQLzAdrbdCkcQKHsJ38gE3zECAEE.u44m8c4RXP1TLsJqGLmTgTQ8z.E77.g3I356oe5NFNWXrn3yuJlJ6KQ7u3XX6cOfYIgMLUApRlJaMFuG1lem0kIQkPJzSwyLYS7Ee6QzOdOr5B0eeqgemdDYGlTnj93Zk4jyQr3StCUoCETnbET3P5.tNIkswlqR3NKTXnBY78yWjIKwq6ezxXLLSWecLqpbukpaCIKU0M8J3m8h.9G8Rxb2zrVLSeNowRXvdIYyZ6QD.ASlFWjvPhvaze9yIFKWST8.MVk9JXJqDkXl93b9aEyCMmFZQC3z2BIkS5sX13D3fqiGXywphICQOIzlZDU3_q8UpqWQE2EmZzxZJVww5QcWDm6q3nMyF8sppeMkLZilkNgFaBxWCk_drZC4Ww.9dagK3zmfDOZshPdyr4PN30jJNlRcSdgTh7ui.AAMsF1Ao6nX.1GVtiDvBIGNCGH9PZCxbEJCwCfOFDE2z1GsLuUK4ldx6xA9tDBXOi7.i7QohA.MtpGAM_oIvw7Z1VuVq0M6tafOOuwSuv_1Iptp5UkJgokHzf1wnPBvfcEWD5U_ybSMQD2.o_pm9AX5LIyOTtgtj44RCWh.AZulnL8koALhH3ZgWtIDBWojfm_xImwZOvhEhoDvGjKRzXothe9zigaAN4B7emeSYuif8YTpm9C7eaDxg_p42df.a2ZQ2tIMyaMDVgXCCeiljoWSzubRZINZ_7uM2tzh.J2aCSAAFwT_X24SaGWwpQjVpZRCXj3ozLxZ1PbYRklhPV1pe8.hLkA0T8OQHDcML7dKhCGLa90_0Ua7aspJbajj4I0gR0JT5ajynMVVy1ZiGg7IyFXzGUeTR3ZYZTH7TLze_KKuakeOh6f47qaVsPePmkHWWx6NsZZ5OwT3npzj4GtK4FYj0tNaWKlUc9SBCucS14W9ypomyM_oBIY3qkC1yiPSn.SgzJ8eAO1RmbexLMtsXpwqNSugb0UGqBnNa.O05Jvwn6ZsG__PskoAHNmhm7FwreIp4qOp4UXxsBHGQQBGFHdWsRzrdpZBz4oG4Wr1NHv70jVT9kLQkvVHDFJoYQ3piCF3uHCCdx05P6Sc1836wLp1eRq7FAGhjLZjNnrZqa7iYdY04.veav0a416FYjSEDU4NK0xV_uQMvk95jwN.WUHy28OOHD.LlJS.t8AWdGB.wnkWP9QUFloeR5HFZH8nPSfilLkwbUUgzMdNUn1AkrQ8cATGXIOJME3JPu0GR2GVdmRInI2EMleBDnPi0VOssnOJuaAbTrn2_txxf7Dnqkha3vaGHDaoAJiQEaDCFushB2K5eBHVxzcc0ZtmcFmLZYQAuHe_OhXg4GfWhZns.BA6X0U.lJqNdS36fE.uaTtyA1B13yrgL0JVxDfawhayoBGCkxkIEQ7_mEhMgfIlUdhXxfu_gvIS9P4FQGu6rmO8lRElXJKpDx.rrC7yrIowQCy6QTs7hjQg20Kn9Ts3aJXZuaUJDACkzm8i60RejIE2GQheZQvKO3b1ZI_Z6hq6RqeTBW1GuyG20Ss24LKvkp0qsJ7bauWPKU54Doi2oKSs7Bv9KGSvS92_27f67h6Li6j8mtLsgBt08zUtrJ.ryDDyDWD1AfKLGEQ7bCC2.KstPt0APiPtbQzxBNXT1UwMHWQYcGdFzNvJ6Wr.p7gMvmHseCtc8VU54D7HfeCm9BS.F3Vh4UCT_jpU7GnJBSIk3UuA3YTAjk1JSaetjjUT5SiPdHkBemiT80lOzA9YShAEdXYCSgY0y8WU0j3sGJ1XEdPognFZkg0ltXb,mdrd: hJ4HjDMZes3n.Oe3GlOaXb8e4IYePZh_HkcvAvMVtcg-1735241440-1.2.1.1-JUGI4SbiYC4LtPrY1.LugDOnWakx.YlobAKc66YBAGFfD1NJtoCMBpTEoBi3.UYr7fFhLO0bcSGfg.WqgbbR4bC_MVlT_QfGvLT9hCMpMxkRf2zZ_6djd1T9LUOKRWZ1up7pe2YOr6_Fll4CC_XtwovNybfIdF.u_gkIOaMxTRipY6FvKBAIg_H3Mt3z5TV0v36HqnIFwMOxsAVM4Bpm96Du6i4EryHw.OqB24lo.N4Ocf._OQCenWxEio3wSqrqWotWNWvZ0TT3A2jE6o8_h42KZiIAfH23Wx1sdEK_TDdA6wkBW4qvdKtcT1nyiy2OVocgiK8Nle918F56cELcTzQBQIQybI.FTKu28FrG7OGdq9GTK719F.ggPBCLR89j8qKrdxPZHSq58TjtxRolK0vc1o0lkpQE7E8TgKSdtPUMkkqLdrP7Dq0dD2wIigk3FcZ3lCasrQmMsedLl3aAQW1jP.i4_kbNhMDcdcJZExBTzHumQeg_4xublPjlOhs3YmTeye7t9KQ5FRF1hMGgPmgIlzA4I7kMxHjum0qN8sHh9j3rUhZR3.QATQZk4UcTZeSrW6kw2TtIiU4XFuVhGF.NOkwDccQOzFXmeGz5xlaQGiJdfvvJigwdI2ubSozbZ3MuUEvqbRPNErhjYZ5OLmf6E2Vr0xpzCuBUeUxyNrcMbxxfhlizQLy9qQPiL_Cr15zWH3RGeQ.6cNZUYrCI0VYjm9reqcR7skPP4SsODLJZDNF3KQPUiTHWverz3jAu2Tmr12jwm2QjOHJoYoE4pHFBuA61xWotHbBMrboc0Fe54ZGDJ8c8beLkITQJdFnGbS2wOkQISsOi0uFdnhm9JMb.PkZq6N6kEmFjFHuGA7T4Ra04L6MfMJbmmfbPBGdzLyacHy63gs_M8KWgkHHQSc63258uzoYh6w_5ZN99AKPjIZzYHPo8fcEtKHr_6eWRpCJ0KVKnltG3yQ0aD3qm_OxCPnZh8WvgegV9FDyGVFU3r9eo2bwsrIx1rB0xoQsZ1rmtaiA2QckvWpJfERLlBnyG_qfPXJ1A4UOZ5NkJzN.36ApbG1WuuwF07ke.1mVK53BnaO2Pak1J8acB4_CpqLdFqEMgrTzbwNbZcTOub9_UqUVaOiVVQ1FvPk10v8A99xINyYcgFPdCWhFUdcI9FlG7r1Ofa3L8CQX1H_LSnbCznRRBdgunAsLZiNRbjhn2.U59fcX_NVjUS9JeZpbXEFOIcOw9CCFrBCI6.vscKdOHq8aPNmLXzYVyImPW1wWvqK9778n6KXRfCUAjIrSmk8Tsdeg.VfIg7C87ziB.opMlB40hkXMtmIgYoYyFF11wKnoCloTgrXNfdKHA3WDB51JYJIu9n1FLWxSabED0CojsFCoXDHTCwgqwjcaiwJBCzr2gpF_bJoJc2L4AC5veW_EqSkTdXlHgR_CAoHM0c9g8D5.GrVva0yp.qw0GXotfM.ifjsWzCe8sMuu8yCQVoI6cVuuCZDed8oR_W4G.Zx_AtaLxX8DA9IHRDcPrN4UVVi54CsOrHzyuQa2rUtsMLERYsZHyNGKNnI13d39XQpris2jD.9z.i0BQLJ_L3nmhZ0VlXNnY5B0CnoMceu.bSyp_DjsXDzcrha5zzwXOG5JIgFZaBB2DCKGAEyBqgk7PULmlI0UZyLXLV8jcY5C1mDoIz9uOqVtjB2Z6YeES.vd4FGqmYKSW0jWzHuUkaVw21Dnm.XxIrtspEz65r9AD9ndBApjntegeanEuTkNLz71UtRaXwcZasV_wqvv6zJmmjlY4RKYCrqvnr_7OXz3ZsXGTNTHWzBY4m1g.RF8pAp4};var cpo  document.createElement(script);cpo.src  /cdn-cgi/challenge-platform/h/b/orchestrate/chl_page/v1?ray8f837c9bd8ee2f27;window._cf_chl_opt.cOgUHash  location.hash   && location.href.indexOf(#) ! -1 ? # : location.hash;window._cf_chl_opt.cOgUQuery  location.search   && location.href.slice(0, location.href.length - window._cf_chl_opt.cOgUHash.length).indexOf(?) ! -1 ? ? : location.search;if (window.history && window.history.replaceState) {var ogU  location.pathname + window._cf_chl_opt.cOgUQuery + window._cf_chl_opt.cOgUHash;history.replaceState(null, null, \/?__cf_chl_rt_tkUF15sgPLJ7ctjbii6.LBGDrh5sLL3iGKaNro5w6Itec-1735241440-1.0.1.1-Ac9rwdB5j1YiUo2HXdruPJXi_bzQTYdGZtQa9XwtYfc + window._cf_chl_opt.cOgUHash);cpo.onload  function() {history.replaceState(null, null, ogU);}}document.getElementsByTagName(head)0.appendChild(cpo);}());/script>/body>/html>

View on OTX | View on ThreatMiner

Data with thanks to AlienVault OTX, VirusTotal, Malwr and others. [Sitemap]

Domain > academie.crescendopharma.com

Is this malicious?

DNS Resolutions

Port 80

Port 443